Stay updated with breaking news from Harmony Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
28.03.2023 - WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) resulting from allegations that Harmony Biosciences may ...
Operator: Good morning everyone. My name is Todd and I will be your conference operator today.
HRMY earnings call for the period ending December 31, 2022.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Brokerages expect Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Rating) to report $99.35 million in sales for the current quarter, Zacks Investment Research reports. Four analysts have provided estimates for Harmony Biosciences’ earnings. The highest sales estimate is $100.50 million and the lowest is $96.88 million. Harmony Biosciences posted sales of $73.82 million in the […]